Connection
Michael Bristow to Adrenergic alpha-Antagonists
This is a "connection" page, showing publications Michael Bristow has written about Adrenergic alpha-Antagonists.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.272 |
|
|
|
-
Pittenger B, Gill EA, Holcslaw TL, Bristow MR. Relation of dose of carvedilol to reduction in QT dispersion in patients with mild to moderate heart failure secondary to ischemic or to idiopathic dilated cardiomyopathy. Am J Cardiol. 2004 Dec 01; 94(11):1459-62.
Score: 0.236
-
Green RD, Lefever GS, Sheys EM, Bristow M. On the specificity of alpha adrenergic receptor labeling by 14C-dibenamine. J Pharmacol Exp Ther. 1973 Dec; 187(3):524-8.
Score: 0.028
-
Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med. 1996 May 23; 334(21):1349-55.
Score: 0.008